ES2472367B1 - Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica - Google Patents

Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica Download PDF

Info

Publication number
ES2472367B1
ES2472367B1 ES201300033A ES201300033A ES2472367B1 ES 2472367 B1 ES2472367 B1 ES 2472367B1 ES 201300033 A ES201300033 A ES 201300033A ES 201300033 A ES201300033 A ES 201300033A ES 2472367 B1 ES2472367 B1 ES 2472367B1
Authority
ES
Spain
Prior art keywords
symmetric
antitumor
choline kinase
kinase inhibitors
antimalarial activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201300033A
Other languages
English (en)
Other versions
ES2472367A1 (es
Inventor
Ana CONEJO GARCÍA
Antonio José ENTRENA GUADIX
Belén RUBIO RUIZ
Miguel Ángel Gallo Mezo
Antonio Espinosa Úbeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Granada
Original Assignee
Universidad de Granada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Granada filed Critical Universidad de Granada
Priority to ES201300033A priority Critical patent/ES2472367B1/es
Publication of ES2472367A1 publication Critical patent/ES2472367A1/es
Application granted granted Critical
Publication of ES2472367B1 publication Critical patent/ES2472367B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica.#La presente invención se enmarca en el campo farmacéutico, concretamente la invención se refiere a compuestos no simétricos de bispiridinio inhibidores de la enzima colina quinasa, su síntesis y su uso como medicamento antitumoral y/o antiparasitario.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
imagen33
imagen34
imagen35
imagen36
imagen37
imagen38
imagen39
imagen40

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
    imagen5
    imagen6
    imagen7
    imagen8
    imagen9
    imagen10
ES201300033A 2012-12-28 2012-12-28 Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica Active ES2472367B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201300033A ES2472367B1 (es) 2012-12-28 2012-12-28 Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201300033A ES2472367B1 (es) 2012-12-28 2012-12-28 Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica

Publications (2)

Publication Number Publication Date
ES2472367A1 ES2472367A1 (es) 2014-06-30
ES2472367B1 true ES2472367B1 (es) 2015-06-02

Family

ID=50980796

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201300033A Active ES2472367B1 (es) 2012-12-28 2012-12-28 Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica

Country Status (1)

Country Link
ES (1) ES2472367B1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237332B1 (es) * 2004-01-14 2006-11-01 Consejo Sup. Investig. Cientificas Derivados de piridinio y quinolinio.

Also Published As

Publication number Publication date
ES2472367A1 (es) 2014-06-30

Similar Documents

Publication Publication Date Title
HRP20192202T1 (hr) Acc inhibitori i njihove upotrebe
DOP2018000088A (es) Amidas heterocíclicas como inhibidores de cinasas
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
ECSP14033037A (es) Síntesis de compuestos heterocíclicos
CR20140464A (es) Compuestos de heterociclilo
ECSP14013284A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
CR20140567A (es) Formulaciones y métodos para la administración vaginal de antiprogestinas
CO7131375A2 (es) Uracilos sustituidos bicíclicamente y uso de los mismos
HRP20220766T1 (hr) Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora
CL2015003444A1 (es) Compuestos de 3,4 dihidroisoquinolin-2(1h)-ilo
DK2925272T3 (da) Lægemiddelopbevarings-, udleverings- og administrationssystem
NZ602035A (en) Adhesive skin patch comprising with an adhesive layer and a support containing a drug
CL2015000408A1 (es) Compuestos derivados de pirazolo[4,3-d]pirimidina y sus sales; composicion farmaceutica que los comprende, util para el tratamiento de enfermedades alergicas, inflamatorias, infecciosas o cancer.
EA201690478A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТРИАЗОЛ[4,5-d]ПИРИМИДИНА
CO7400876A2 (es) Etanercept correctamente plegado de alta pureza y excelente rendimiento
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
CL2014000849A1 (es) Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas.
CO6890098A2 (es) Compuesto pirazol y su uso farmaceutico
ZA201405949B (en) Pharmaceutical preparation containing and antivirally active dihydroquinazoline derivative
EA201590688A1 (ru) Производные n-проп-2-инилкарбоксамида и их применение в качестве антагонистов trpa1
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора
UY33874A (es) Derivados de ácido 3-heteroaroilamino-propiónico sustituidos y su uso como sustancias farmacéuticas
UY34154A (es) Dosificación y administración de anticuerpos anti-erbb3 en combinación con paclitaxel.
ES2472367B1 (es) Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica
EA201500313A1 (ru) Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2472367

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150602